Skip to main content
. 2021 Sep 29;61(1):5–18. doi: 10.1002/mc.23355

Figure 3.

Figure 3

Decision curve analyses (DCA) for the evaluation of the clinical net‐benefit using the preoperative Cox models for the prediction of (A) recurrence‐free survival (RFS), (B) cancer‐specific survival (CSS), and (C) overall survival (OS) [Color figure can be viewed at wileyonlinelibrary.com]